Blackbird Critical Metals announces that it has entered into a definitive share purchase agreement, dated August 13, 2025 with Lir Life Sciences, a party at arm's length to the Company, pursuant to which it has agreed to acquire 100% of the issued and outstanding common shares in the capital of Lir Life Sciences in consideration for the issuance of at least 21,807,143 common shares in the capital of the Company, on a post-Consolidation basis, to the Lir Life Sciences shareholders , as of the date of closing of the Acquisition, on a pro-rata basis , subject to the terms and conditions set out within the Purchase Agreement. The Acquisition represents a "Fundamental Change" of the Company under the Canadian Securities Exchange's Policy 8 - Fundamental Changes and Ch...